ProfileGDS4718 / 220592_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 38% 39% 37% 39% 36% 35% 33% 45% 38% 36% 36% 42% 37% 36% 40% 39% 35% 38% 39% 43% 44% 34% 37% 36% 33% 39% 35% 33% 33% 34% 37% 32% 33% 38% 34% 36% 34% 39% 42% 40% 34% 35% 34% 34% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.8886738
GSM549102patient 115, normal, homogenized [OPG study]4.9739
GSM549104patient 119, normal, homogenized [OPG study]4.8437737
GSM549108patient 138, normal, homogenized [OPG study]5.0215339
GSM549119patient 077, normal, homogenized [OPG study]4.8365236
GSM549133patient 032, cancer, homogenized [OPG study]4.7057935
GSM549139patient 042, cancer, homogenized [OPG study]4.6480833
GSM549099patient 107, normal, homogenized [OPG study]5.2677345
GSM549109patient 139, normal, homogenized [OPG study]4.936938
GSM549110patient 046, normal, homogenized [OPG study]4.8234336
GSM549114patient 063, normal, homogenized [OPG study]4.7543736
GSM549122patient 082, normal, homogenized [OPG study]5.0864842
GSM549134patient 033, cancer, homogenized [OPG study]4.8342937
GSM549136patient 036, cancer, homogenized [OPG study]4.735336
GSM549140patient 044, cancer, homogenized [OPG study]4.9501840
GSM549111patient 047, normal, homogenized [OPG study]4.9132539
GSM549113patient 057, normal, homogenized [OPG study]4.6907935
GSM549132patient 031, cancer, homogenized [OPG study]4.893938
GSM549137patient 038, cancer, homogenized [OPG study]4.9308139
GSM549142patient 047, cancer, homogenized [OPG study]5.2640343
GSM549100patient 110, normal, homogenized [OPG study]5.2218244
GSM549107patient 135, normal, homogenized [OPG study]4.6917234
GSM549115patient 068, normal, homogenized [OPG study]4.780137
GSM549116patient 072, normal, homogenized [OPG study]4.7933336
GSM549120patient 078, normal, homogenized [OPG study]4.6852333
GSM549131patient 030, cancer, homogenized [OPG study]4.9026939
GSM549118patient 074, normal, homogenized [OPG study]4.7678735
GSM549129patient 027, cancer, homogenized [OPG study]4.688833
GSM549123patient 088, normal, homogenized [OPG study]4.6542133
GSM549124patient 006, cancer, homogenized [OPG study]4.7790334
GSM549126patient 015, cancer, homogenized [OPG study]4.8524337
GSM549128patient 025, cancer, homogenized [OPG study]4.5984932
GSM549103patient 117, normal, homogenized [OPG study]4.7298133
GSM549117patient 073, normal, homogenized [OPG study]4.8570738
GSM549138patient 041, cancer, homogenized [OPG study]4.6758434
GSM549141patient 045, cancer, homogenized [OPG study]4.7550336
GSM549130patient 028, cancer, homogenized [OPG study]4.7097734
GSM549101patient 111, normal, homogenized [OPG study]4.9900639
GSM549105patient 128, normal, homogenized [OPG study]5.0943142
GSM549106patient 134, normal, homogenized [OPG study]4.9572140
GSM549112patient 048, normal, homogenized [OPG study]4.7193334
GSM549125patient 011, cancer, homogenized [OPG study]4.7704435
GSM549127patient 024, cancer, homogenized [OPG study]4.6914234
GSM549135patient 035, cancer, homogenized [OPG study]4.6795434